Axil Brands, Inc. (AXIL) stock
AXILNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 6, 2026Score 19/3059% below fair value
$5.19+0.06 (+1.18%)
Close on Nov 13, 2026Market cap $35.41MP/E 15.3Yield –
Axil Brands ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Axil Brands's ebitda for the twelve months ending Aug 31, 2026 was $3.25M, up 70.2% year over year. For fiscal 2026 it was $3.22M, up 146.1% from the year before. The highest annual figure on record is $3.22M in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $3.22M | +146.1% |
| FY2025 | May 31, 2025 | $1.31M | -19.8% |
| FY2024 | May 31, 2024 | $1.63M | -21.4% |
| FY2023 | May 31, 2023 | $2.08M | – |
| FY2022 | May 31, 2022 | -$203.53K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $502.57K | +6.1% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $1.51M | +1387.2% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $268.61K | -57.3% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $970.59K | +37.2% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $473.83K | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $101.58K | -53.1% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $628.78K | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $707.31K | -45.2% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$127.81K | -163.3% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $216.57K | -66.7% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$76.27K | -131.7% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $1.29M | +28.1% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $201.99K | -7.8% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $650.17K | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $240.52K | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $1.01M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $219.07K | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$92.92K | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$95.37K | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$3.11K | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$12.13K | – |
See a number that looks wrong?